Printer Friendly

COMPANY INFORMATION
Pacgen Biopharmaceuticals Corporation One Bentall Centre, 1730-505 Burrard St Vancouver, BC V7X 1M6 Tel: (604) 436-4388 Fax: (604) 436-4380 Contact Name Christina Yip Industry Biotechnology		Key Executives Yiu Chung Lee, CEO Christina Yip, CFO Develops peptide therapeutic drugs for the prevention and treatment of infectious diseases and immune system regulation diseases.
FP ADVISOR COVERAGE Pacgen Biopharmaceuticals Corporation • FP Corporate Surveys • Ordering FP Products		TOP INDUSTRY PLAYERS Biotechnology Company Name Revenue ($000s)  Atrium Innovations Inc. 309,546 Angiotech Pharmaceuticals, Inc. 302,251 QLT Inc. 132,457 Oncothyreon Inc. 42,678 AEterna Zentaris Inc. 41,056 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF JAN 22/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX-VEN/PGA $0.03 $0.12 $0.02 n.a. n.a. n.a. n.a. Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 50 n.a. $-0.02 Sept. 30/09 -28.57% -66.24% n.a. $954
ANNUAL FINANCIALS Periods ended: 12m Mar. 31/09 12m Mar. 31/08 12m Mar. 31/07 $000s $000s $000s Net income (2,283) (5,975) (4,354) Total assets 1,677 3,024 7,835 $ $ $ Earnings per share* (0.06) (0.19) (0.20) % % % Return on equity n.m. (146.86) (111.27)   * Common

COMPANY NEWS

Results for 'Pacgen Biopharmaceuticals Corporation' from past 30 days: No hits. (Links are to articles.)